News
01.04.2020
Covid-19 outbreak – AZ-Biopharm can support you in drug manufacturing, QC and drug development
Meanwhile almost all countries are affected by the virus spread putting many especially elderly people on high risk to die. And although in a few countries one observes that the infection rates are slowing down and scientists around the world are doing a great job to discover a vaccine, there is no mid-term solution for an effective vaccine on the horizon.
Meanwhile, many researchers trying to fight the virus with established medicines for the treatment of malaria and other viruses like EBOLA or MERS-COV and SARS-COV (https://www.elsevier.com/__data/assets/pdf_file/0007/988648/COVID-19-Drug-Therapy_Mar-2020.pdf). We at AZ-Biopharm (www.az-Biopharm.de) have experience with such drugs and can provide assays for the drug product, for API and for pharmacokinetics for clinics on short notice.
